Carl Dambkowski Apogee Therapeutics, Inc. (APGE) insider trading activity

APGE Quotes by TradingView
Shares Held (Direct Ownership) 271K
16.08% 3M change
5.05% 12M change
Total Value Held N/A

Carl Dambkowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2025
SELL
Open market or private sale
$817,500 $75.0 p/Share
10,900 Reduced 3.87%
271,108 Common Stock
Nov 05 2025
SELL
Open market or private sale
$594,684 $55.14 p/Share
10,785 Reduced 3.68%
282,008 Common Stock
Nov 05 2025
BUY
Exercise of conversion of derivative security
$184,251 $22.86 p/Share
8,060 Added 2.68%
292,793 Common Stock
Oct 01 2025
SELL
Open market or private sale
$203,378 $39.8 p/Share
5,110 Reduced 1.76%
284,733 Common Stock
Oct 01 2025
BUY
Exercise of conversion of derivative security
$54,521 $22.86 p/Share
2,385 Added 0.82%
289,843 Common Stock
Sep 03 2025
SELL
Open market or private sale
$104,040 $38.18 p/Share
2,725 Reduced 1.15%
233,548 Common Stock
Aug 06 2025
SELL
Open market or private sale
$102,950 $37.78 p/Share
2,725 Reduced 1.14%
236,273 Common Stock
Jul 02 2025
SELL
Open market or private sale
$459,195 $45.51 p/Share
10,090 Reduced 4.05%
238,998 Common Stock
Jul 02 2025
BUY
Exercise of conversion of derivative security
$168,363 $22.86 p/Share
7,365 Added 2.87%
249,088 Common Stock
Jun 04 2025
SELL
Open market or private sale
$100,716 $36.96 p/Share
2,725 Reduced 1.11%
241,723 Common Stock
May 07 2025
SELL
Open market or private sale
$97,418 $35.75 p/Share
2,725 Reduced 1.1%
244,448 Common Stock
Apr 02 2025
SELL
Open market or private sale
$141,777 $36.73 p/Share
3,860 Reduced 1.54%
247,173 Common Stock
Mar 05 2025
SELL
Open market or private sale
$48,463 $30.48 p/Share
1,590 Reduced 0.63%
251,033 Common Stock
Feb 05 2025
SELL
Open market or private sale
$143,228 $40.69 p/Share
3,520 Reduced 1.37%
252,623 Common Stock
Feb 05 2025
BUY
Exercise of conversion of derivative security
$18,173 $22.86 p/Share
795 Added 0.31%
256,143 Common Stock
Jan 02 2025
SELL
Open market or private sale
$192,730 $47.18 p/Share
4,085 Reduced 1.57%
255,348 Common Stock
Jan 02 2025
BUY
Exercise of conversion of derivative security
$31,089 $22.86 p/Share
1,360 Added 0.52%
259,433 Common Stock
Dec 11 2024
SELL
Open market or private sale
$223,867 $49.31 p/Share
4,540 Reduced 1.73%
258,073 Common Stock
Dec 11 2024
BUY
Exercise of conversion of derivative security
$41,490 $22.86 p/Share
1,815 Added 0.69%
262,613 Common Stock
Dec 04 2024
SELL
Open market or private sale
$307,056 $46.07 p/Share
6,665 Reduced 2.49%
260,798 Common Stock
Nov 06 2024
SELL
Open market or private sale
$396,100 $59.43 p/Share
6,665 Reduced 2.43%
267,463 Common Stock
Oct 02 2024
SELL
Open market or private sale
$376,639 $56.51 p/Share
6,665 Reduced 2.37%
274,128 Common Stock
Sep 04 2024
SELL
Open market or private sale
$318,453 $47.78 p/Share
6,665 Reduced 2.32%
280,793 Common Stock
Aug 07 2024
SELL
Open market or private sale
$303,448 $41.37 p/Share
7,335 Reduced 2.49%
287,458 Common Stock
Jul 03 2024
SELL
Open market or private sale
$226,191 $37.73 p/Share
5,995 Reduced 1.99%
294,793 Common Stock

Also insider at

ABIO
ARCA biopharma, Inc. Healthcare
Director
CD

Carl Dambkowski

Chief Medical Officer
Waltham, MA

Track Institutional and Insider Activities on APGE

Follow Apogee Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APGE shares.

Notify only if

Insider Trading

Get notified when an Apogee Therapeutics, Inc. insider buys or sells APGE shares.

Notify only if

News

Receive news related to Apogee Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APGE